Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium
一项针对复发或难治性神经母细胞瘤患者的随机II期试验:MIBG对比MIBG、长春新碱和伊立替康对比MIBG和伏立诺他:来自NANT联盟的报告
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.00703
DuBois, Steven G; Granger, M Meaghan; Groshen, Susan; Tsao-Wei, Denice; Ji, Lingyun; Shamirian, Anasheh; Czarnecki, Scarlett; Goodarzian, Fariba; Berkovich, Rachel; Shimada, Hiroyuki; Villablanca, Judith G; Vo, Kieuhoa T; Pinto, Navin; Mosse, Yael P; Maris, John M; Shusterman, Suzanne; Cohn, Susan L; Goldsmith, Kelly C; Weiss, Brian; Yanik, Gregory A; Twist, Clare J; Irwin, Meredith S; Haas-Kogan, Daphne A; Park, Julie R; Marachelian, Araz; Matthay, Katherine K